日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years

接受 Lanadelumab 治疗 3 年或以上的遗传性血管性水肿患者的长期真实世界结果

Lumry, William R; Davis-Lorton, Mark; Soteres, Daniel; Earl, Lucy; Wynne-Cattanach, Kieran; Fox, Daniel; Sing, Krystal; Juethner, Salomé; Schultz, Bob G

Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis

接受拉那德鲁单抗或其他长期预防治疗的遗传性血管性水肿患者的真实世界生活质量

Davis-Lorton, Mark; Soteres, Daniel; Lumry, William R; Hall, Jennifer; Connolly, Hannah; Fox, Daniel; Sing, Krystal; Schultz, Bob G; Juethner, Salomé

Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study

Lanadelumab 长期预防治疗遗传性血管性水肿的持续有效性、耐受性和安全性:前瞻性、4 期、非干预性 EMPOWER 真实世界研究

Bernstein, Jonathan A; Betschel, Stephen D; Busse, Paula J; Banerji, Aleena; Wedner, H James; Manning, Michael; Zaragoza-Urdaz, Rafael H; Anderson, John; Gagnon, Remi; Baptist, Alan P; Soteres, Daniel; Lumry, William R; Craig, Timothy; Petroni, Daniel; Hsu, F Ida; Nova Estepan, Daniel; Juethner, Salomé; Watt, Maureen; Khutoryansky, Natalie; Zuraw, Bruce L

Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S

KONFIDENT-S 研究中,Sebetralstat 用于按需治疗粘膜遗传性血管性水肿发作。

Bernstein, Jonathan A; Aygören-Pürsün, Emel; Cancian, Mauro; Cohn, Danny M; Craig, Timothy; Grivcheva-Panovska, Vesna; Jordan, Anthony; Lumry, William R; Martinez-Saguer, Inmaculada; Melamed, Isaac; Ohmura, Kazumasa; Peter, Jonny; Riedl, Marc A; Soteres, Daniel F; Staubach, Petra; Stobiecki, Marcin; Chuang, Ya-Hsiu; Smith, Michael D; Yea, Christopher M; Audhya, Paul K; Zanichelli, Andrea; Farkas, Henriette

Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study

按遗传性血管性水肿类型划分的医生和患者报告结局:来自真实世界研究的数据

Anderson, John; Soteres, Daniel; Mellor, Jennifer; Connolly, Hannah; Wynne-Cattanach, Kieran; Earl, Lucy; Schultz, Bob G; Juethner, Salome

Glacier fluctuations in the northern Patagonian Andes (44°S) imply wind-modulated interhemispheric in-phase climate shifts during Termination 1

巴塔哥尼亚北部安第斯山脉(南纬44°)的冰川波动表明,在第一阶段末期,风调制了半球间同相气候变化。

Soteres, Rodrigo L; Sagredo, Esteban A; Kaplan, Michael R; Martini, Mateo A; Moreno, Patricio I; Reynhout, Scott A; Schwartz, Roseanne; Schaefer, Joerg M

Patient and caregiver perspectives on transitioning to oral prophylaxis in the emerging hereditary angioedema treatment landscape

在遗传性血管性水肿治疗领域,患者和照护者对过渡到口服预防性治疗的看法

Soteres, Daniel F; Grimes, Fellicia

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps

NAVIGATE I:氟替卡松呼气给药系统治疗伴有鼻息肉的慢性鼻窦炎的随机、安慰剂对照、双盲试验

Sindwani, Raj; Han, Joseph K; Soteres, Daniel F; Messina, John C; Carothers, Jennifer L; Mahmoud, Ramy A; Djupesland, Per G

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study

在 3 期遗传性血管性水肿预防试验中评估口服激肽释放酶抑制剂 avoralstat:OPuS-2 研究

Riedl, M A; Aygören-Pürsün, E; Baker, J; Farkas, H; Anderson, J; Bernstein, J A; Bouillet, L; Busse, P; Manning, M; Magerl, M; Gompels, M; Huissoon, A P; Longhurst, H; Lumry, W; Ritchie, B; Shapiro, R; Soteres, D; Banerji, A; Cancian, M; Johnston, D T; Craig, T J; Launay, D; Li, H H; Liebhaber, M; Nickel, T; Offenberger, J; Rae, W; Schrijvers, R; Triggiani, M; Wedner, H J; Dobo, S; Cornpropst, M; Clemons, D; Fang, L; Collis, P; Sheridan, W P; Maurer, M

Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings

使用 Cinryze® 预防儿童遗传性血管性水肿发作:3 期中期疗效和安全性研究结果

Aygören-Pürsün, Emel; Soteres, Daniel; Moldovan, Dumitru; Christensen, Jim; Van Leerberghe, Arthur; Hao, James; Schranz, Jennifer; Jacobson, Kraig W; Martinez-Saguer, Inmaculada